GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (NYSE:TARO) » Definitions » Cyclically Adjusted Book per Share

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Cyclically Adjusted Book per Share : $53.99 (As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is Taro Pharmaceutical Industries Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Taro Pharmaceutical Industries's adjusted book value per share for the three months ended in Dec. 2023 was $47.336. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $53.99 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 13.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 14.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 17.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Taro Pharmaceutical Industries was 45.80% per year. The lowest was 4.10% per year. And the median was 16.60% per year.

As of today (2024-04-27), Taro Pharmaceutical Industries's current stock price is $42.40. Taro Pharmaceutical Industries's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $53.99. Taro Pharmaceutical Industries's Cyclically Adjusted PB Ratio of today is 0.79.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Taro Pharmaceutical Industries was 12.24. The lowest was 0.47. And the median was 3.66.


Taro Pharmaceutical Industries Cyclically Adjusted Book per Share Historical Data

The historical data trend for Taro Pharmaceutical Industries's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Cyclically Adjusted Book per Share Chart

Taro Pharmaceutical Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.42 35.88 40.46 47.02 51.81

Taro Pharmaceutical Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 51.81 52.86 53.70 53.99

Competitive Comparison of Taro Pharmaceutical Industries's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taro Pharmaceutical Industries's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Taro Pharmaceutical Industries's Cyclically Adjusted PB Ratio falls into.



Taro Pharmaceutical Industries Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Taro Pharmaceutical Industries's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=47.336/129.4194*129.4194
=47.336

Current CPI (Dec. 2023) = 129.4194.

Taro Pharmaceutical Industries Quarterly Data

Book Value per Share CPI Adj_Book
201403 23.709 99.695 30.778
201406 25.232 100.560 32.473
201409 27.956 100.428 36.026
201412 30.742 99.070 40.160
201503 32.958 99.621 42.816
201506 35.587 100.684 45.744
201509 37.588 100.392 48.456
201512 41.312 99.792 53.577
201603 45.156 100.470 58.167
201606 44.742 101.688 56.944
201609 46.631 101.861 59.247
201612 48.643 101.863 61.802
201703 51.033 102.862 64.209
201706 52.810 103.349 66.132
201709 54.885 104.136 68.211
201712 54.819 104.011 68.210
201803 55.929 105.290 68.747
201806 57.693 106.317 70.230
201809 60.032 106.507 72.947
201812 47.155 105.998 57.574
201903 49.445 107.251 59.665
201906 51.097 108.070 61.192
201909 52.561 108.329 62.794
201912 53.529 108.420 63.897
202003 54.991 108.902 65.352
202006 43.998 108.767 52.352
202009 45.166 109.815 53.229
202012 45.995 109.897 54.166
202103 44.920 111.754 52.020
202106 43.718 114.631 49.358
202109 44.516 115.734 49.780
202112 45.140 117.630 49.664
202203 45.536 121.301 48.584
202206 45.596 125.017 47.202
202209 45.398 125.227 46.918
202212 0.000 125.222 0.000
202303 46.052 127.348 46.801
202306 46.256 128.729 46.504
202309 46.497 129.860 46.339
202312 47.336 129.419 47.336

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Taro Pharmaceutical Industries  (NYSE:TARO) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Taro Pharmaceutical Industries's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=42.40/53.99
=0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Taro Pharmaceutical Industries was 12.24. The lowest was 0.47. And the median was 3.66.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Taro Pharmaceutical Industries Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description

Traded in Other Exchanges
Address
14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Executives
Sun Pharma Global Inc 10 percent owner
Sun Pharmaceutical Industries Ltd 10 percent owner, other: Affiliated Party 17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST) K7 400 093
Alkaloida Chemical Co Exclusive Group Ltd. 10 percent owner KABAY JANOS UT 29., TISZAVASVARI K5 4440
Franklin Resources Inc 10 percent owner FRANKLIN RESOURCES INC, ONE FRANKLIN PARKWAY, SAN MATEO CA 94403

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Headlines

From GuruFocus

Taro to Release First Quarter Results on July 27, 2022

By Business Wire Business Wire 07-26-2022

Taro to Announce Full Year Results on May 19, 2021

By Business Wire Business Wire 05-12-2021

Taro to Announce Second Quarter Results on October 28, 2021

By Business Wire Business Wire 10-21-2021

Taro to Announce Third Quarter Results on January 27, 2021

By Business Wire Business Wire 01-21-2021

Taro to Release Full Year Results on May 23, 2023

By Business Wire Business Wire 05-18-2023

Taro to Acquire Alchemee From Galderma

By Business Wire Business Wire 02-22-2022

Taro to Announce First Quarter Results on July 29, 2020

By Business Wire Business Wire 07-22-2020